Abstract
Oral cancer accounts for 2-3% of all malignancies and according to the World Health Organization (WHO) is the fifth most common cancer worldwide. On the other hand, “oxidative stress” implies a cellular state whereby reactive oxygen species (ROS) production exceeds its metabolism resulting in excessive ROS accumulation and overwhelmed cellular defenses. Such a state has been shown to be involved in the multistage process of human carcinogenesis (including oral cancer) via many different mechanisms. Amongst them are ROS-induced oxidative modifications on major cellular macromolecules like DNA, proteins and lipids with the resulting byproducts being involved in the pathophysiology of human oral malignant and pre-malignant lesions. Throughout this manuscript, we review the current state of knowledge on the role of these oxidativemodified cellular byproducts in serving as reliable biomarkers for oral cancer detection, prognosis and diagnosis.
Keywords: Reactive Oxygen Species (ROS), Oxidative Stress, Lipid Oxidation, DNA Oxidation, Protein Oxidation, Oral Carcinogenesis, OSCC, Leukoplakia, Lichen Planus, Submucous Fibrosis, tobacco, infection, intraoral cancer, chemotherapy, radiotherapy
Current Molecular Medicine
Title:Oxidative Stress Based-Biomarkers in Oral Carcinogenesis: How Far Have We Gone?
Volume: 12 Issue: 6
Author(s): R. Hanafi, I. Anestopoulos, G. P. Voulgaridou, R. Franco, A. G. Georgakilas, D. Ziech, V. Malamou-Mitsi, A. Pappa and M. I. Panayiotidis
Affiliation:
Keywords: Reactive Oxygen Species (ROS), Oxidative Stress, Lipid Oxidation, DNA Oxidation, Protein Oxidation, Oral Carcinogenesis, OSCC, Leukoplakia, Lichen Planus, Submucous Fibrosis, tobacco, infection, intraoral cancer, chemotherapy, radiotherapy
Abstract: Oral cancer accounts for 2-3% of all malignancies and according to the World Health Organization (WHO) is the fifth most common cancer worldwide. On the other hand, “oxidative stress” implies a cellular state whereby reactive oxygen species (ROS) production exceeds its metabolism resulting in excessive ROS accumulation and overwhelmed cellular defenses. Such a state has been shown to be involved in the multistage process of human carcinogenesis (including oral cancer) via many different mechanisms. Amongst them are ROS-induced oxidative modifications on major cellular macromolecules like DNA, proteins and lipids with the resulting byproducts being involved in the pathophysiology of human oral malignant and pre-malignant lesions. Throughout this manuscript, we review the current state of knowledge on the role of these oxidativemodified cellular byproducts in serving as reliable biomarkers for oral cancer detection, prognosis and diagnosis.
Export Options
About this article
Cite this article as:
Hanafi R., Anestopoulos I., P. Voulgaridou G., Franco R., G. Georgakilas A., Ziech D., Malamou-Mitsi V., Pappa A. and I. Panayiotidis M., Oxidative Stress Based-Biomarkers in Oral Carcinogenesis: How Far Have We Gone?, Current Molecular Medicine 2012; 12 (6) . https://dx.doi.org/10.2174/156652412800792598
DOI https://dx.doi.org/10.2174/156652412800792598 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Advances in the Development of Anticancer Drugs Targeting Tyrosine Kinases of the Src Family
Current Drug Therapy Small Molecule Inhibitors of Stat3 Signaling Pathway
Current Cancer Drug Targets Synthesis of 99mTc-Nimotuzumab with Tricarbonyl Ion: in vitro and in vivo Studies
Current Radiopharmaceuticals A Functional Scaffold in Marine Alkaloid: An Anticancer Moiety for Human
Current Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Targeting ATP7A to Increase the Sensitivity of Neuroblastoma Cells to Retinoid Therapy
Current Cancer Drug Targets Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine
Current Pharmaceutical Design Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells
Current Pharmaceutical Design New Trends in the Development of Transcription Factor Decoy (TFD) Pharmacotherapy
Current Drug Targets Near-Infrared Dyes: Probe Development and Applications in Optical Molecular Imaging
Current Organic Synthesis Recent Advances and Approaches in Targeting Apoptosis Signaling Pathways for Anti-Cancer Therapeutics
Current Cancer Therapy Reviews Safety of Cabergoline in the Management of Pituitary Prolactin-Induced Symptoms with Patients Treated with Atypical Neuroleptics
Current Drug Safety EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Current Cancer Drug Targets Current and Future Scenario of Immunotherapy for the Treatment of Hepatocellular Carcinoma
Current Cancer Therapy Reviews Glycolipid Antigen – Mediated Invariant NKT Cell Activation in Microbial Immunity
Current Immunology Reviews (Discontinued) Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics Differences in Phosphorylated Histone H2AX Foci Formation and Removal of Cells Exposed to Low and High Linear Energy Transfer Radiation
Current Genomics The Potential of Natural Products as Effective Treatments for Allergic Inflammation: Implications for Allergic Rhinitis
Current Topics in Medicinal Chemistry Imaging in the Age of Molecular Medicine: Monitoring of Anti-Angiogenic Treatments
Current Pharmaceutical Biotechnology Hybrid Benzoxazole-Coumarin Compounds Induce Death Receptor-Mediated Switchable Apoptotic and Necroptotic Cell Death on HN-5 Head and Neck Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry